Hypertrophic Cardiomyopathy Without Obstruction: Clinical Trials

3 trials for Hypertrophic Cardiomyopathy Without Obstruction, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 recruiting, 1 active not recruiting. 1 Early Phase 1, 1 Not applicable.

By phase and status

PhaseTrialsStatus
Early Phase 11Active not recruiting 1
Not applicable1Recruiting 1

Follow Hypertrophic Cardiomyopathy Without Obstruction: new trials by email Literature Review of Hypertrophic Cardiomyopathy Without Obstruction trials Research Report on Hypertrophic Cardiomyopathy Without Obstruction

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Exercise Prescription in Children With Hypertrophic Cardiomyopathy
Exercise Prescription - Hypertrophic Cardiomyopathy Without Obstruction
Not applicableRecruitingAlder Hey Children's NHS Foundation Trust102025-12-242026-05-19
Study of the Progression of Chronic Cardiovascular Conditions
Cardiovascular Disease (CVD), Heart Failure
RecruitingProlaio50002025-10-302026-08-12
Sodium Glucose Co-transporter (SGLT) Inhibitors in Nonobstructive Hypertrophic Cardiomyopathy
Sotagliflozin - Hypertrophic Cardiomyopathy Without Obstruction
Early Phase 1Active not recruitingUniversity of Pennsylvania262024-12-172026-11-09

Narrower conditions

Cardiomyopathy, Hypertrophic (2)  ·  Aortic Valve Stenosis (1)  ·  Cardiomyopathy, Dilated (1)  ·  Cardiovascular Diseases (1)  ·  Heart Failure (1)  ·  Hypertension (1)  ·  familial dilated cardiomyopathy (1)

Broader conditions

Aortic Stenosis, Subvalvular (2)  ·  Aortic Valve Disease (2)  ·  Cardiomyopathies (2)  ·  Heart Diseases (2)  ·  Heart Valve Diseases (2)  ·  Aortic Valve Stenosis (1)  ·  Cardiomegaly (1)  ·  Cardiovascular Diseases (1)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1)  ·  Genetic Diseases, Inborn (1)  ·  Laminopathies (1)  ·  Vascular Diseases (1)  ·  Ventricular Outflow Obstruction (1)

Interventions

(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol (1)

Sponsors

Alder Hey Children's NHS Foundation Trust (1)  ·  Prolaio (1)  ·  University of Pennsylvania (1)

Countries

United States (2)  ·  United Kingdom (1)

Top investigators

Sharlene Day, MD (1)

NIH funding

R61HL164376 (1)